key: cord-1002864-bp03a0xp authors: Gelardi, Matteo; Trecca, Eleonora M.C.; Fortunato, Francesca; Iannuzzi, Lucia; Ronca, Gianluca; Quaranta, Nicola A.A.; Cassano, Michele title: COVID-19 lockdown and seasonal allergic rhinitis: our experience in 40 patients date: 2021-05-12 journal: Acta Biomed DOI: 10.23750/abm.v92i2.10953 sha: 07f890f6b0bebb9b80d5586936f5d94a4f6736cc doc_id: 1002864 cord_uid: bp03a0xp INTRODUCTION: The aim of this article was to study the course of seasonal allergic rhinitis during COVID-19 lockdown to understand if being quarantined at home for a long time can constitute a protective factor for allergic patients. MATERIALS AND METHODS: Telehealth consultations were performed by the departments of Otolaryngology of Foggia and Bari University Hospitals. Patients affected by cypress pollen allergy took part in a phone interview and were asked about their sinonasal symptoms during the COVID-19 lockdown, by answering the sinonasal outcome test (I-SNOT-22) questionnaire. Further data concerning the medications used to treat allergy and the number of days per month in which they were used were collected. The responses about the COVID-19 lockdown were compared to those obtained by the same patients in our clinics the previous year. The statistical analysis was executed by using the paired sample t-test and the Bartlett test considering as significant values with p values <0.05. RESULTS: Forty patients affected by cypress pollen allergy visited at Foggia and Bari University Hospitals were enrolled in this study. All I-SNOT-22 scores concerning the COVID-19 lockdown were lower than those of the previous year; moreover, 18 (81.8%) clinical parameters were statistically significant (p<0.05). Also, in regard to the treatment, results about COVID-19 lockdown were overall better than those of 2019, with 50% (n=3) of the investigated drugs, reporting statistical significance (p<0.05). CONCLUSIONS: The present study was able to evidence the fundamental role of primary prevention in Allergology. Paradoxically, the home quarantine ordered by the Italian Government appeared to be an effective measure not only in the fight against COVID-19 but also against pollen exposure. (www.actabiomedica.it) Italy was the first European country to be hit by the COVID-19 pandemic, which has already profoundly impacted the way of living of the global population (1) . Although rhinology is now in the spotlight with the latest publications about smell and taste impairment in COVID-19 patients (2, 3) , allergology is ap-parently in the background. However, allergic rhinitis will continue to be one of the most common diseases even in the post-COVID-19 era (4, 5) and there are many questions that need further research. For example, an interesting point would be to investigate the influence that the new daily habits and restrictions have on the clinical history of the various allergic diseases. Therefore, the aim of this article was to study the course of seasonal allergic rhinitis during lockdown in order to understand if being quarantined at home for a long time, in addition to being the best measure to control the spread of SARS-CoV-2 infection, can constitute a protective factor for allergic patients. The first step in planning this research was to check the pollen count (http://www.pollinieallergie.it) of the two months of study (March 2019/ March 2020). In the Puglia region outdoor ambient pollen levels were characterized by high concentration (> 90 grains per m 3 of air) of 'Cupressaceae' (Cypress family). Values in 2020 coincided with those in 2019, both as regards the pollen concentration (average levels oscillating between 100 and 380 grains per m 3 of air) and the duration (pollen peak levels around the 9 th week of the year). In accordance with the guidelines from the Higher Institute of Health (ISS) and due to the sanitary restrictions, telehealth consultations (6) were performed by the departments of Otolaryngology (ORL) of Foggia and Bari University Hospitals. Patients affected by cypress pollen allergy confirmed by skin prick test took part in a phone interview and were asked about the sinonasal symptoms during the COVID-19 lockdown, from March 9 th to April 9 th , 2020, by answering the sinonasal outcome test (I-SNOT-22) questionnaire (7) (8) (9) . This last questionnaire was chosen as a statistically significant correlation (p<0.001) was demonstrated between SNOT-22 and Rhinitis Control Assessment Test (RCAT) (10, 11) . Further data concerning the medications used to treat allergy and the number of days per month in which they were used were collected. The responses about the COVID-19 lockdown were compared to those obtained by the same patients in our clinics the previous year, from March 9 th to April 9 th , 2019. After a verbal explanation, all participants gave their oral informed consent to participate in phone interviews. Patients in essential jobs, such as health workers, security guards, policemen, and transport workers, were not included in this study since they had to go out for work even during the Italian lockdown. Other exclusion criteria were: poliallergic patients, subjects with additional non-allergic rhinitis, patients with uncontrolled symptoms of asthma, as well as subjects who underwent immunotherapy and/or changed medications. The assessment of significant differences among the means of continuous variables was calculated by using the paired sample t-test considering as significant values with p values <0.05. The Bartlett test was used to assess the distribution of the variables. P values <0.05 were considered significant. Data analyses were carried out using STATA-MP software, version 15. This research was approved by the Institutional Review Board of the Department of Otolaryngology of the University Hospital of Foggia and conducted in accordance with Guideline for Good Clinical Practice and the ethical principles originating in the Declaration of Helsinki. Twelve patients who fulfilled the inclusion criteria did not answer and, after two attempts to reach them by phone, were therefore excluded. Finally, forty patients affected by cypress pollen allergy (18 males, 22 females; median age 36.5) visited at the Otolaryngology (ORL) Departments of Foggia and Bari University Hospitals were enrolled in this study. Out of this group, 14 (35%) individuals were allergic to multiple allergens, but, when the investigation was performed, it was not the season of the other pollen allergies. Eleven subjects (27.5%) were atopic and 14 (35%) were familiar for the disease. As concerns the comorbidities, 11 (27.5%) subjects were asthmatic and 3 (7.5%) had aspirin sensitivity. None of the patients had nasal polyps. Our results confirmed that the lockdown ordered by the Italian government has positively influenced the clinical history of patients with seasonal allergic rhinitis. All I-SNOT-22 scores concerning the COVID-19 lockdown were lower than those of the previous year (Table 1) ; moreover, 18 (81.8%) clinical parameters were statistically significant (p<0.05). Also, in regard to the treatment, results about COVID-19 lockdown were overall better than those of 2019 (Table 2) , with 50% (n=3) of the investigated drugs, such as "systemic antihistamines", "topical corticosteroids" and "nasal decongestants", reporting statistical significance (p<0.05). Our data evidenced the general well-being that patients have referred and are consistent with the reduced pollen exposure. The restrictions imposed by the lockdown are in accordance with the indications suggested by the ARIA (Allergic Rhinitis and its Im-pact on Asthma) guidelines (4), according to which limiting pollen exposure in both indoor and outdoor environments is the most effective primary preventive measure in subjects with respiratory allergies. Conversely, as evidenced by a study recently published by our group (12) , the clinical history of patients with dust mite allergy was negatively influenced by the COVID-19 restrictions, which forced patients to stay at home for a long time with increased allergen exposure. Also, it would be interesting to see what is going to happen to patients affected by other seasonal pollen allergies (i.e., gramineous, olive pollen etc.) during the next months, in order to release international guidelines and integrated strategies to improve the quality of life of allergic patients during the COVID-19 pandemic and limiting the costs for the health system already under pressure during these unprecedented times. This should be warranted also for pediatric patients, since the etiology of asthma and allergic rhinitis are influenced by genetic and environmental factors as well (13) . Even when the lockdown is going to be lifted, allergic patients will probably benefit from the use of masks. In fact, masks help to create an oronasal barrier and, in addition to being an effective preventive measure for COVID-19, they can protect allergic patients from pollen exposure. Although the study period was short enough to evaluate any reductions in infectious complications, the use of masks may also induce a decrease in infectious rhinitis that may support the general well-being of allergic patients. Certainly, the lockdown represents an exceptional experimental model, but it also has some limitations. In fact, Italian hospitals were active only for urgent/ emergent procedures and more objective measures such as laboratory findings could not confirm the subjective improvement experienced by our patients. Although the present study was carried out in an extraordinary context that no one would have ever expected, it was able to evidence the fundamental role of primary prevention in Allergology. Paradoxically, the home quarantine ordered by the Italian Government to all citizens appeared to be an effective measure not only in the fight against COVID-19 but also against pollen exposure. Environmental factors appeared to play a role of primary importance in the pathogenesis of allergic rhinitis and the design of "pollen free towns" should be considered in a future perspective. Additionally, telemedicine, mobile applications (14) and phone counselling in cooperation with primary care physicians, which were effective strategies during the COVID-19 pandemic, should constitute the basis also of the Allergology of the post-COVID-19 era. Ethical approval: The research was conducted in accordance with Guideline for Good Clinical Practice and the ethical principles originating in the Declaration of Helsinki. Informed consent: All participants gave their informed consent to participate in this research study. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence COVID-19: what happened to all of the otolaryngology emergencies? Eur Arch Oto-Rhino-Laryngology Gestion de la consulta de otorrinolaringología durante el estado de alarma por la pandemia del covid-19. ¿es util la consulta telefónica en orl? Acta Otorrinolaringológica Española Cross-cultural adaptation and validation of the SNOT-22 into Italian. Eur Arch Oto-Rhino-Laryngology Psychometric validity of the 22-item Sinonasal Outcome Test European Position Paper on Rhinosinusitis and Nasal Polyps 2020 Association between Symptoms of Allergic Rhinitis with Decreased General Health-Related Quality of Life Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control COVID-19: When dust mites and lockdown create the perfect storm Asthma and allergic rhinitis in childhood: what's new Cassano M. Mobile Applications in Otolaryngology: A Systematic Review of the Literature, Apple App Store and the Google Play Store Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.